SCHEMBL6648689

SCHEMBL6648689

CC[Si](CC)(CC)OC(/C=C\CC(C)(C)CCCC=O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648702 1.00
SCHEMBL7698667 0.86
SCHEMBL7698672 0.86
SCHEMBL7701671 0.86
SCHEMBL14489225 0.75 FAAH (0.33)
SCHEMBL7700905 0.73 ACLY (0.32)
SCHEMBL6651466 0.73 ACLY (0.32)
SCHEMBL6651471 0.73 ACLY (0.32)
SCHEMBL7698919 0.72 FAAH (0.31)
SCHEMBL7698924 0.72 FAAH (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1094060-B1 New process for the preparation of retiferol derivatives BASILEA PHARMACEUTICA AG (CH) 2004-04-28 EP disclosed
US-6437142-B1 10,10,10-TRIFLUORO-5,5-DIMETHYL-9-TRIETHYLSILANYLOXY-9-TRIFLUO ROMETHYL-DEC-7-ENAL REACTED WITH TRIETHYL PHOSPHONOACETATE OR ETHYL (TRIMETHYLSILYL) ACETATE AND THEN COUPLING WITH 2-MERCAPTO-BENZOTHIAZOLE BASILEA PHARMACEUTICA AG (CH) 2002-08-20 US disclosed
US-6403346-B1 FOR TREATMENT/PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES (PSORIASIS) AND REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE BASILEA PHARMACEUTICA AG (CH) 2002-06-11 US disclosed
US-20020028975-A1 Process for preparing retiferol derivatives HILPERT HANS (CH) 2002-03-07 US disclosed
US-6310262-B1 COUPLING CYCLOHEXANONE DERIVATIVE WITH BENZOTHIAZOLE DERIVATIVE TO FORM RETIFEROL DERIVATIVE BASILEA PHARMACEUTICA AG (CH) 2001-10-30 US disclosed
EP-1094060-A2 New process for the preparation of retiferol derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-04-25 EP disclosed